Skip to main content
. 2024 Jan 31;15:1349543. doi: 10.3389/fphar.2024.1349543

TABLE 1.

Reports of ADEs related to remdesivir and tocilizumab by notifier categories. FAERS (2020–2022).

Notifier Medications
Remdesivir Tocilizumab
n % n %
Physician 1,272 17.8 4,169 21.3
Pharmacist 4,569 63.9 1,437 7.3
Other health professional 679 9.5 5,433 27.7
Lawyer 2 0 2 0
Consumer 401 5.6 8,112 41.4
Missing 224 3.1 449 2.3
Totals 7,147 100 19,602 100